Disbrow Joshua R.'s Form 4/A amendment
AmendedAytu Biopharma, Inc (AYTU) · filed Nov 28, 2022
- Accession no.
- 0001567619-22-020922
- Filed
- Nov 28, 2022, 4:30 PM ET
- Trade date
- Nov 18, 2022
- Filing delay
- 10 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Nov 21, 2022
This filing lists 1 non-derivative transaction. Open-market purchases total $52.6K. It was filed 10 days after the trade.
This amendment replaces 0001654954-22-015599 (filed Nov 21, 2022).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Disbrow Joshua R.CIK 0001566240 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2022 | Common Shares | PPurchaseAcquired | +222,000 | $0.237 | +$52,614 | 1,119,506 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
This amendment has no footnotes.